Document is current
Any future updates will be listed below
-
Authors
Maeda, Haruka
Igarashi, Ataru
Kuwamitsu, Osamu
Morimoto, Konosuke
-
Funding
Funding for this research was provided by:
the Ministry of Health, Labour and Welfare (21HA2008, 23HA2017)
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 9 May 2025
First Online: 26 May 2025
Declarations
:
: This study was conducted in accordance with the principles of the Declaration of Helsinki, the Ethical Guidelines for Medical Research Involving Human Subjects of Japan, and the Act on the Protection of Personal Information of Japan. This study was approved by the Institutional Review Board of the Institute of Tropical Medicine, Nagasaki University (approval no.: 220915281), and a participating medical facility. Informed consent was obtained from all participants via online methods.
: Not applicable
: HM reports lecture and consulting fees from Moderna Inc. and participates in Pfizer Inc-funded research outside this work. AI reports grants from Moderna Japan Inc. and Takeda Pharmaceutical Inc., consulting fees from Pfizer Inc. and Astra Zeneca Inc., and lecture fees from Takeda Pharmaceutical Inc., Shionogi Inc., Janssen Pharma Inc., and Modera Inc. outside this work. KM reports grants from Pfizer Inc., consulting fees from Moderna Inc. and MSD, and lecture fees from MSD outside this work.
